000			01627 a2200517 4500
005			20250517021155.0
264		0	_c20150910
008			201509s 0 0 rus d
022			_a0869-2092
040			_aNLM _beng _cNLM
100	1		_aIvashchenko, A V
245	0	0	_a[Preclinical study of safety of the new pharmacological substance AV0012 to treat hepatitis C]. _h[electronic resource]
260			_bEksperimental'naia i klinicheskaia farmakologiia _c2014
300			_a33-9 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article
650	0	4	_aAnimals
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aFemale
650	0	4	_aHepatitis C _xdrug therapy
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aMacaca mulatta
650	0	4	_aMale
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aMice, Inbred Strains
650	0	4	_aMolecular Structure
650	0	4	_aMutagenicity Tests
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aRats, Wistar
650	0	4	_aToxicity Tests, Acute
650	0	4	_aToxicity Tests, Chronic
650	0	4	_aToxicity Tests, Subchronic
700	1		_aIamanushkin, P M
700	1		_aMit'kin, O D
700	1		_aEzhova, E V
700	1		_aKorzinov, O M
700	1		_aShevkun, N A
700	1		_aKarapetian, R N
700	1		_aBychko, V V
700	1		_aIvashchenko, A A
700	1		_aAgrba, V Z
700	1		_aLapin, B A
700	1		_aOrlov, S V
700	1		_aKuznetsov, I É
773	0		_tEksperimental'naia i klinicheskaia farmakologiia _gvol. 77 _gno. 12 _gp. 33-9
999			_c24677100 _d24677100